ETG-26216-70841
1 vaccination
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-01-22
Registered in v-safe
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Muscle contracture, Uterine hypertonus — Feeling: Fair · Site: Pain · NauseaFree text: Increased contractionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-07-22
-
2022-01-21
Survey response — 12 months, dose 1MedDRA: Nasal congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: I had nasal congestion and runny nose in mid December 2021 and again this week. Covid negative both timesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Increased contractions
Release 10 — 12 months, dose 1
Symptoms: I had nasal congestion and runny nose in mid December 2021 and again this week. Covid negative both times
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Muscle contracture | ✓ | · | ✓ |
| SRO | Uterine hypertonus | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release